✦ LIBER ✦

The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: modifications to the androgen receptor

✍ Scribed by Joanne Edwards; John M.S. Bartlett

Book ID: 109051820
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 188 KB
Volume: 95
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2005.05526.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The androgen receptor and signal-transdu

The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: androgen-receptor cofactors and bypass pathways

✍ Joanne Edwards; John M.S. Bartlett 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB

Key targets of hormonal treatment of pro

Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways

✍ André N. Vis; Fritz H. Schröder 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

KEY TARGETS OF HORMONE TREATMENT OF PROS

KEY TARGETS OF HORMONE TREATMENT OF PROSTATE CANCER. PART I: THE ANDROGEN RECEPTOR AND STEROIDOGENIC PATHWAYS

✍ William R. Pitts 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Interaction of IGF signaling and the and

Interaction of IGF signaling and the androgen receptor in prostate cancer progression

✍ Jennifer D. Wu; Kathy Haugk; Libby Woodke; Peter Nelson; Ilsa Coleman; Stephen R 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB 👁 2 views

## Abstract The insulin‐like growth factor type I receptor (IGF‐IR) has been suggested to play an important role in prostate cancer progression and possibly in the progression to androgen‐independent (AI) disease. The term AI may not be entirely correct, in that recent data suggest that expression

Androgen receptor: A key molecule in the

Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence

✍ Mary-Ellen Taplin; Steven P. Balk 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract Despite earlier detection and recent advances in surgery and radiation, prostate cancer is second only to lung cancer in male cancer deaths in the United States. Hormone therapy in the form of medical or surgical castration remains the mainstay of systemic treatment in prostate cancer.

Amplification of the androgen receptor g

Amplification of the androgen receptor gene is associated with P53 mutation in hormone-refractory recurrent prostate cancer

✍ Koivisto, Pasi A.; Rantala, Immo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 2 views

p53 protein expression of 30 hormone-refractory locally recurrent prostate cancers was compared with their matched untreated primary tumour specimens. In addition, androgen receptor (AR) gene amplification and p53 protein immunostaining were compared. p53 positivity increased during hormonal therapy